StonvexLoading…
StonvexStonvexStonvexCore line items from LIN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $33.99B | $33.01B | $32.85B | $33.36B |
Operating Income | $8.92B | $8.63B | $8.02B | $5.37B |
Net Income | $6.90B | $6.57B | $6.20B | $4.15B |
EPS (Diluted) | $14.61 | $13.62 | $12.59 | $8.23 |
Total Assets | $86.82B | $80.15B | $80.81B | $79.66B |
Total Liabilities | $47.08B | $40.66B | $39.72B | $38.27B |
Cash & Equivalents | $5.06B | $4.85B | $4.66B | $5.44B |
Free Cash Flow OCF − CapEx | $5.09B | $4.93B | $5.52B | $5.69B |
Shares Outstanding | 472.19M | 482.09M | 492.29M | 504.04M |